Publications

Found 2 results
Filters: Author is K.P. Du  [Clear All Filters]
2016
Y. W. Pan, Zhou, Z. G., Wang, M., Dong, J. Q., Du, K. P., Li, S., Liu, Y. L., Lv, P. J., Gao, J. B., Pan, Y. W., Zhou, Z. G., Wang, M., Dong, J. Q., Du, K. P., Li, S., Liu, Y. L., Lv, P. J., and Gao, J. B., Combination of IL-6, IL-10, and MCP-1 with traditional serum tumor markers in lung cancer diagnosis and prognosis, vol. 15, no. 4, p. -, 2016.
Conflicts of interest The authors declare no conflict of interest. ACKNOWLEDGMENTS Research supported by the National Natural Science Fund of China (Grant #81301220). REFERENCES Bhora FY, Chen DJ, Detterbeck FC, et al. (2014). The ITMIG/IASLC thymic epithelial tumors staging project: a proposed lymph node map for thymic epithelial tumors in the forthcoming 8th edition of the TNM classification of malignant tumors. J. Thorac. Oncol. 9: S88-96. Burns TF, Stabile LP, et al (2014). Targeting the estrogen pathway for the treatment and prevention of lung cancer. Lung Cancer Manag. 3: 43-52. http://dx.doi.org/10.2217/lmt.13.67 Chen F, Yan CE, Li J, Han XH, et al (2015a). Diagnostic value of CYFRA 21-1 and CEA for predicting lymph node metastasis in operable lung cancer. Int. J. Clin. Exp. Med. 8: 9820-9824. Chen Y, Zhang F, Tsai Y, Yang X, et al (2015b). IL-6 signaling promotes DNA repair and prevents apoptosis in CD133+ stem-like cells of lung cancer after radiation. Radiat. Oncol. 10: 227. http://dx.doi.org/10.1186/s13014-015-0534-1 Fiala O, Pesek M, Finek J, Svaton M, et al (2016). Prognostic significance of serum tumor markers in patients with advanced-stage NSCLC treated with pemetrexed-based chemotherapy. Anticancer Res. 36: 461-466. Genestreti G, Grossi F, Genova C, Burgio MA, et al (2014). Third- and further-line therapy in advanced non-small-cell lung cancer patients: an overview. Future Oncol. 10: 2081-2096. http://dx.doi.org/10.2217/fon.14.96 Hu L, Ibrahim S, Liu C, Skaar J, et al (2009). Thrombin induces tumor cell cycle activation and spontaneous growth by down-regulation of p27Kip1, in association with the up-regulation of Skp2 and MiR-222. Cancer Res. 69: 3374-3381. http://dx.doi.org/10.1158/0008-5472.CAN-08-4290 Huang Z, Yi X, Luo B, Zhu J, et al (2016). Induced sputum deposition improves diagnostic yields of pulmonary alveolar proteinosis: A clinicopathological and methodological study of 17 cases. Ultrastruct. Pathol. 40: 7-13. http://dx.doi.org/10.3109/01913123.2015.1104404 Lan X, Lan T, Faxiang Q, et al (2015). Interleukin-10 promoter polymorphism and susceptibility to lung cancer: a systematic review and meta-analysis. Int. J. Clin. Exp. Med. 8: 15317-15328. Ma L, Xie XW, Wang HY, Ma LY, et al (2015). Clinical evaluation of tumor markers for diagnosis in patients with non-small cell lung cancer in China. Asian Pac. J. Cancer Prev. 16: 4891-4894. http://dx.doi.org/10.7314/APJCP.2015.16.12.4891 Northcott PA, Fernandez-L A, Hagan JP, Ellison DW, et al (2009). The miR-17/92 polycistron is up-regulated in sonic hedgehog-driven medulloblastomas and induced by N-myc in sonic hedgehog-treated cerebellar neural precursors. Cancer Res. 69: 3249-3255. http://dx.doi.org/10.1158/0008-5472.CAN-08-4710 Ortakoylu MG, Iliaz S, Bahadir A, Aslan A, et al (2015). Diagnostic value of endobronchial ultrasound-guided transbronchial needle aspiration in various lung diseases. J. Bras. Pneumol. 41: 410-414. http://dx.doi.org/10.1590/S1806-37132015000004493 Pang JC, Kwok WK, Chen Z, Ng HK, et al (2009). Oncogenic role of microRNAs in brain tumors. Acta Neuropathol. 117: 599-611. http://dx.doi.org/10.1007/s00401-009-0525-0 Qader AA, Urraca J, Torsetnes SB, Tønnesen F, et al (2014). Peptide imprinted receptors for the determination of the small cell lung cancer associated biomarker progastrin releasing peptide. J. Chromatogr. A 1370: 56-62. http://dx.doi.org/10.1016/j.chroma.2014.10.023 Reddy SP, Natarajan V, Dudek AZ, et al (2014). MARCKS is marked in combating lung cancer growth and acquired resistance. Am. J. Respir. Crit. Care Med. 190: 1084-1086. http://dx.doi.org/10.1164/rccm.201410-1922ED Sasaki S, Yoshioka Y, Ko R, Katsura Y, et al (2016). Diagnostic significance of cerebrospinal fluid EGFR mutation analysis for leptomeningeal metastasis in non-small-cell lung cancer patients harboring an active EGFR mutation following gefitinib therapy failure. Respir. Investig. 54: 14-19. http://dx.doi.org/10.1016/j.resinv.2015.07.001 Shi P, Meng X, Ni M, Sun X, et al (2015). Association between serum tumor markers and metabolic tumor volume or total lesion glycolysis in patients with recurrent small cell lung cancer. Oncol. Lett. 10: 3123-3128. Shinke H, Masuda S, Togashi Y, Ikemi Y, et al (2015). Urinary kidney injury molecule-1 and monocyte chemotactic protein-1 are noninvasive biomarkers of cisplatin-induced nephrotoxicity in lung cancer patients. Cancer Chemother. Pharmacol. 76: 989-996. http://dx.doi.org/10.1007/s00280-015-2880-y Xiao H, Liu Y, Tan H, Liang P, et al (2015). A pilot study using low-dose Spectral CT and ASIR (Adaptive Statistical Iterative Reconstruction) algorithm to diagnose solitary pulmonary nodules. BMC Med. Imaging 15: 54. http://dx.doi.org/10.1186/s12880-015-0096-6 Yang J, Wei F, Schafer C, Wong DT, et al (2014). Detection of tumor cell-specific mRNA and protein in exosome-like microvesicles from blood and saliva. PLoS One 9: e110641. http://dx.doi.org/10.1371/journal.pone.0110641 Yang L, Shi GL, Song CX, Xu SF, et al (2010). Relationship between genetic polymorphism of MCP-1 and non-small-cell lung cancer in the Han nationality of North China. Genet. Mol. Res. 9: 765-771. http://dx.doi.org/10.4238/vol9-2gmr740 Zaric B, Stojsic V, Carapic V, Kovacevic T, et al (2016). Radial endobronchial ultrasound (EBUS) guided suction catheter-biopsy in histological diagnosis of peripheral pulmonary lesions. J. Cancer 7: 7-13. http://dx.doi.org/10.7150/jca.13081 Zhao K, Xu J, Tian H, et al (2016). Correlation analysis between an IL-6 genetic polymorphism and non-small cell lung cancer prognosis. Genet. Mol. Res. 15: 15017021. http://dx.doi.org/10.4238/gmr.15017021
Y. W. Pan, Zhou, Z. G., Wang, M., Dong, J. Q., Du, K. P., Li, S., Liu, Y. L., Lv, P. J., Gao, J. B., Pan, Y. W., Zhou, Z. G., Wang, M., Dong, J. Q., Du, K. P., Li, S., Liu, Y. L., Lv, P. J., and Gao, J. B., Combination of IL-6, IL-10, and MCP-1 with traditional serum tumor markers in lung cancer diagnosis and prognosis, vol. 15, no. 4, p. -, 2016.
Conflicts of interest The authors declare no conflict of interest. ACKNOWLEDGMENTS Research supported by the National Natural Science Fund of China (Grant #81301220). REFERENCES Bhora FY, Chen DJ, Detterbeck FC, et al. (2014). The ITMIG/IASLC thymic epithelial tumors staging project: a proposed lymph node map for thymic epithelial tumors in the forthcoming 8th edition of the TNM classification of malignant tumors. J. Thorac. Oncol. 9: S88-96. Burns TF, Stabile LP, et al (2014). Targeting the estrogen pathway for the treatment and prevention of lung cancer. Lung Cancer Manag. 3: 43-52. http://dx.doi.org/10.2217/lmt.13.67 Chen F, Yan CE, Li J, Han XH, et al (2015a). Diagnostic value of CYFRA 21-1 and CEA for predicting lymph node metastasis in operable lung cancer. Int. J. Clin. Exp. Med. 8: 9820-9824. Chen Y, Zhang F, Tsai Y, Yang X, et al (2015b). IL-6 signaling promotes DNA repair and prevents apoptosis in CD133+ stem-like cells of lung cancer after radiation. Radiat. Oncol. 10: 227. http://dx.doi.org/10.1186/s13014-015-0534-1 Fiala O, Pesek M, Finek J, Svaton M, et al (2016). Prognostic significance of serum tumor markers in patients with advanced-stage NSCLC treated with pemetrexed-based chemotherapy. Anticancer Res. 36: 461-466. Genestreti G, Grossi F, Genova C, Burgio MA, et al (2014). Third- and further-line therapy in advanced non-small-cell lung cancer patients: an overview. Future Oncol. 10: 2081-2096. http://dx.doi.org/10.2217/fon.14.96 Hu L, Ibrahim S, Liu C, Skaar J, et al (2009). Thrombin induces tumor cell cycle activation and spontaneous growth by down-regulation of p27Kip1, in association with the up-regulation of Skp2 and MiR-222. Cancer Res. 69: 3374-3381. http://dx.doi.org/10.1158/0008-5472.CAN-08-4290 Huang Z, Yi X, Luo B, Zhu J, et al (2016). Induced sputum deposition improves diagnostic yields of pulmonary alveolar proteinosis: A clinicopathological and methodological study of 17 cases. Ultrastruct. Pathol. 40: 7-13. http://dx.doi.org/10.3109/01913123.2015.1104404 Lan X, Lan T, Faxiang Q, et al (2015). Interleukin-10 promoter polymorphism and susceptibility to lung cancer: a systematic review and meta-analysis. Int. J. Clin. Exp. Med. 8: 15317-15328. Ma L, Xie XW, Wang HY, Ma LY, et al (2015). Clinical evaluation of tumor markers for diagnosis in patients with non-small cell lung cancer in China. Asian Pac. J. Cancer Prev. 16: 4891-4894. http://dx.doi.org/10.7314/APJCP.2015.16.12.4891 Northcott PA, Fernandez-L A, Hagan JP, Ellison DW, et al (2009). The miR-17/92 polycistron is up-regulated in sonic hedgehog-driven medulloblastomas and induced by N-myc in sonic hedgehog-treated cerebellar neural precursors. Cancer Res. 69: 3249-3255. http://dx.doi.org/10.1158/0008-5472.CAN-08-4710 Ortakoylu MG, Iliaz S, Bahadir A, Aslan A, et al (2015). Diagnostic value of endobronchial ultrasound-guided transbronchial needle aspiration in various lung diseases. J. Bras. Pneumol. 41: 410-414. http://dx.doi.org/10.1590/S1806-37132015000004493 Pang JC, Kwok WK, Chen Z, Ng HK, et al (2009). Oncogenic role of microRNAs in brain tumors. Acta Neuropathol. 117: 599-611. http://dx.doi.org/10.1007/s00401-009-0525-0 Qader AA, Urraca J, Torsetnes SB, Tønnesen F, et al (2014). Peptide imprinted receptors for the determination of the small cell lung cancer associated biomarker progastrin releasing peptide. J. Chromatogr. A 1370: 56-62. http://dx.doi.org/10.1016/j.chroma.2014.10.023 Reddy SP, Natarajan V, Dudek AZ, et al (2014). MARCKS is marked in combating lung cancer growth and acquired resistance. Am. J. Respir. Crit. Care Med. 190: 1084-1086. http://dx.doi.org/10.1164/rccm.201410-1922ED Sasaki S, Yoshioka Y, Ko R, Katsura Y, et al (2016). Diagnostic significance of cerebrospinal fluid EGFR mutation analysis for leptomeningeal metastasis in non-small-cell lung cancer patients harboring an active EGFR mutation following gefitinib therapy failure. Respir. Investig. 54: 14-19. http://dx.doi.org/10.1016/j.resinv.2015.07.001 Shi P, Meng X, Ni M, Sun X, et al (2015). Association between serum tumor markers and metabolic tumor volume or total lesion glycolysis in patients with recurrent small cell lung cancer. Oncol. Lett. 10: 3123-3128. Shinke H, Masuda S, Togashi Y, Ikemi Y, et al (2015). Urinary kidney injury molecule-1 and monocyte chemotactic protein-1 are noninvasive biomarkers of cisplatin-induced nephrotoxicity in lung cancer patients. Cancer Chemother. Pharmacol. 76: 989-996. http://dx.doi.org/10.1007/s00280-015-2880-y Xiao H, Liu Y, Tan H, Liang P, et al (2015). A pilot study using low-dose Spectral CT and ASIR (Adaptive Statistical Iterative Reconstruction) algorithm to diagnose solitary pulmonary nodules. BMC Med. Imaging 15: 54. http://dx.doi.org/10.1186/s12880-015-0096-6 Yang J, Wei F, Schafer C, Wong DT, et al (2014). Detection of tumor cell-specific mRNA and protein in exosome-like microvesicles from blood and saliva. PLoS One 9: e110641. http://dx.doi.org/10.1371/journal.pone.0110641 Yang L, Shi GL, Song CX, Xu SF, et al (2010). Relationship between genetic polymorphism of MCP-1 and non-small-cell lung cancer in the Han nationality of North China. Genet. Mol. Res. 9: 765-771. http://dx.doi.org/10.4238/vol9-2gmr740 Zaric B, Stojsic V, Carapic V, Kovacevic T, et al (2016). Radial endobronchial ultrasound (EBUS) guided suction catheter-biopsy in histological diagnosis of peripheral pulmonary lesions. J. Cancer 7: 7-13. http://dx.doi.org/10.7150/jca.13081 Zhao K, Xu J, Tian H, et al (2016). Correlation analysis between an IL-6 genetic polymorphism and non-small cell lung cancer prognosis. Genet. Mol. Res. 15: 15017021. http://dx.doi.org/10.4238/gmr.15017021